Movalis (Meloxicam)

Meloxicam, the active ingredient in Movalis, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as a injectable solution for intramuscular use. It treats osteoarthritis pain, rheumatoid arthritis pain, acute musculoskeletal pain and post‑operative pain in adult patients.

GNH USA supplies Movalis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is used to manage pain and inflammation associated with several musculoskeletal conditions. - Osteoarthritis pain: reduces joint inflammation and relieves chronic pain. - Rheumatoid arthritis pain: alleviates joint swelling and discomfort in rheumatoid arthritis. - Acute musculoskeletal pain: provides rapid analgesia for sprains, strains and other acute injuries. - Post‑operative pain: controls pain following surgical procedures.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Injection‑site reactions: pain, erythema, or swelling.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury. - Hepatic dysfunction or elevated liver enzymes. - Cardiovascular thrombotic events. - Anaphylactic or severe hypersensitivity reactions.

Careful assessment and monitoring are required when using meloxicam injectable solution. - Renal function: evaluate baseline renal status and monitor during therapy. - Hepatic function: check liver enzymes before initiation and periodically thereafter. - Cardiovascular risk: use cautiously in patients with known heart disease or hypertension. - Gastrointestinal risk: avoid in individuals with a history of ulcer disease or bleeding. - Hypersensitivity: discontinue if signs of severe allergic reaction appear. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - ACE inhibitors or ARBs: heightened risk of renal impairment.

Moderate Interactions (Monitor Closely): - Diuretics: may reduce renal perfusion, requiring renal function monitoring. - SSRIs or SNRIs: potential for increased bleeding tendency.